B A Lynch1, K A Loiacono, C L Tiong
1ARIAD Pharmaceuticals Inc., Cambridge, Massachusetts 02139, USA.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
We developed a fluorescence polarization assay to screen for inhibitors of the Src-SH2 domain, crucial for signaling pathways in diseases like cancer. This assay is robust and suitable for high-throughput screening of drug compounds.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: